These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

408 related articles for article (PubMed ID: 32912799)

  • 21. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neuroendocrine-Metabolic Dysfunction and Sleep Disturbances in Neurodegenerative Disorders: Focus on Alzheimer's Disease and Melatonin.
    Spinedi E; Cardinali DP
    Neuroendocrinology; 2019; 108(4):354-364. PubMed ID: 30368508
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synaptic Mitochondria: An Early Target of Amyloid-β and Tau in Alzheimer's Disease.
    Torres AK; Jara C; Park-Kang HS; Polanco CM; Tapia D; Alarcón F; de la Peña A; Llanquinao J; Vargas-Mardones G; Indo JA; Inestrosa NC; Tapia-Rojas C
    J Alzheimers Dis; 2021; 84(4):1391-1414. PubMed ID: 34719499
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Associations of informant-based sleep reports with Alzheimer's disease pathologies.
    Shokouhi S
    Clin Interv Aging; 2019; 14():1631-1642. PubMed ID: 31571843
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Candidate mechanisms underlying the association between sleep-wake disruptions and Alzheimer's disease.
    Cedernaes J; Osorio RS; Varga AW; Kam K; Schiöth HB; Benedict C
    Sleep Med Rev; 2017 Feb; 31():102-111. PubMed ID: 26996255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. It's complicated: The relationship between sleep and Alzheimer's disease in humans.
    Lucey BP
    Neurobiol Dis; 2020 Oct; 144():105031. PubMed ID: 32738506
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Is Sleep Disruption a Cause or Consequence of Alzheimer's Disease? Reviewing Its Possible Role as a Biomarker.
    Lloret MA; Cervera-Ferri A; Nepomuceno M; Monllor P; Esteve D; Lloret A
    Int J Mol Sci; 2020 Feb; 21(3):. PubMed ID: 32050587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Circadian and sleep dysfunction in Alzheimer's disease.
    Uddin MS; Tewari D; Mamun AA; Kabir MT; Niaz K; Wahed MII; Barreto GE; Ashraf GM
    Ageing Res Rev; 2020 Jul; 60():101046. PubMed ID: 32171783
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Obstructive sleep apnea and Alzheimer's disease-related cerebrospinal fluid biomarkers in mild cognitive impairment.
    Díaz-Román M; Pulopulos MM; Baquero M; Salvador A; Cuevas A; Ferrer I; Ciopat O; Gómez E
    Sleep; 2021 Jan; 44(1):. PubMed ID: 32728730
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tau-related grey matter network breakdown across the Alzheimer's disease continuum.
    Pelkmans W; Ossenkoppele R; Dicks E; Strandberg O; Barkhof F; Tijms BM; Pereira JB; Hansson O
    Alzheimers Res Ther; 2021 Aug; 13(1):138. PubMed ID: 34389066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Theranostic F-SLOH mitigates Alzheimer's disease pathology involving TFEB and ameliorates cognitive functions in Alzheimer's disease models.
    Iyaswamy A; Wang X; Krishnamoorthi S; Kaliamoorthy V; Sreenivasmurthy SG; Kumar Durairajan SS; Song JX; Tong BC; Zhu Z; Su CF; Liu J; Cheung KH; Lu JH; Tan JQ; Li HW; Wong MS; Li M
    Redox Biol; 2022 May; 51():102280. PubMed ID: 35286997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacological and non-pharmacological interventions to enhance sleep in mild cognitive impairment and mild Alzheimer's disease: A systematic review.
    Blackman J; Swirski M; Clynes J; Harding S; Leng Y; Coulthard E
    J Sleep Res; 2021 Aug; 30(4):e13229. PubMed ID: 33289311
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease.
    Maass A; Landau S; Baker SL; Horng A; Lockhart SN; La Joie R; Rabinovici GD; Jagust WJ;
    Neuroimage; 2017 Aug; 157():448-463. PubMed ID: 28587897
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rates of regional tau accumulation in ageing and across the Alzheimer's disease continuum: an AIBL
    Krishnadas N; Doré V; Robertson JS; Ward L; Fowler C; Masters CL; Bourgeat P; Fripp J; Villemagne VL; Rowe CC
    EBioMedicine; 2023 Feb; 88():104450. PubMed ID: 36709581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sex differences in Alzheimer's disease: plasma MMP-9 and markers of disease severity.
    Tsiknia AA; Sundermann EE; Reas ET; Edland SD; Brewer JB; Galasko D; Banks SJ;
    Alzheimers Res Ther; 2022 Nov; 14(1):160. PubMed ID: 36324151
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The zinc dyshomeostasis hypothesis of Alzheimer's disease.
    Craddock TJ; Tuszynski JA; Chopra D; Casey N; Goldstein LE; Hameroff SR; Tanzi RE
    PLoS One; 2012; 7(3):e33552. PubMed ID: 22457776
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Toxic Amyloid-β42 Conformer May Accelerate the Onset of Alzheimer's Disease in the Preclinical Stage.
    Futamura A; Hieda S; Mori Y; Kasuga K; Sugimoto A; Kasai H; Kuroda T; Yano S; Tsuji M; Ikeuchi T; Irie K; Ono K
    J Alzheimers Dis; 2021; 80(2):639-646. PubMed ID: 33579852
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regional White Matter Hyperintensities and Alzheimer's Disease Biomarkers Among Older Adults with Normal Cognition and Mild Cognitive Impairment.
    Newton P; Tchounguen J; Pettigrew C; Lim C; Lin Z; Lu H; Moghekar A; Albert M; Soldan A;
    J Alzheimers Dis; 2023; 92(1):323-339. PubMed ID: 36744337
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NREM sleep as a novel protective cognitive reserve factor in the face of Alzheimer's disease pathology.
    Zavecz Z; Shah VD; Murillo OG; Vallat R; Mander BA; Winer JR; Jagust WJ; Walker MP
    BMC Med; 2023 May; 21(1):156. PubMed ID: 37138290
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cognitive impairment in late-life bipolar disorder is not associated with Alzheimer's disease pathological signature in the cerebrospinal fluid.
    Forlenza OV; Aprahamian I; Radanovic M; Talib LL; Camargo MZ; Stella F; Machado-Vieira R; Gattaz WF
    Bipolar Disord; 2016 Feb; 18(1):63-70. PubMed ID: 26876913
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.